Literature DB >> 26055090

Ischemic postconditioning provides cardioprotective and antiapoptotic effects against ischemia-reperfusion injury through iNOS inhibition in hyperthyroid rats.

Jalal Zaman1, Sajad Jeddi1, Maryam Sadat Daneshpour2, Maryam Zarkesh2, Zahra Daneshian2, Asghar Ghasemi3.   

Abstract

Ischemic postconditioning (IPost) is a strategy to provide protection against ischemia-reperfusion (IR) injury. The cardioprotective effects of IPost in cases of ischemic heart disease along with co-morbidities like hyperthyroidism remain unknown. The aim of this study was to investigate the effects of IPost on expression of eNOS, iNOS, Bax, and Bcl-2 genes in hyperthyroid male rats, subjected to myocardial IR. Hyperthyroidism was induced by adding thyroxine to drinking water for a period of 21 days. Using the Langendorff device hearts were perfused, then subjected to a 30-minute global ischemia which was followed by 120 min of reperfusion; subsequently IPost was induced immediately after ischemia. Results indicated that following IR, expression of eNOS and Bcl-2 decreased, whereas expression of iNOS and Bax increased in both the control and hyperthyroid groups. In hyperthyroid animals, IPost significantly increased expression of eNOS by 3.19 fold and Bcl-2 by 3.66 fold; it also decreased expression of Bax by 51%, and reduced IR-induced DNA laddering pattern and infarct size (45.7 ± 1.82% vs. 59.3 ± 1.83%, p<0.05) in the presence of aminoguanidine (AG), a selective iNOS inhibitor. In conclusion, IPost per se could not provide cardioprotection against myocardial ischemia in hyperthyroid rats, a loss of which however was restored by the combination of IPost and iNOS inhibition that acts by a decrease in Bax and an increase in both eNOS and Bcl-2 expression.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gene expression; Hyperthyroidism; Ischemia; Postconditioning

Mesh:

Substances:

Year:  2015        PMID: 26055090     DOI: 10.1016/j.gene.2015.06.011

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Role of inducible nitric oxide synthase in myocardial ischemia-reperfusion injury in sleep-deprived rats.

Authors:  Sajad Jeddi; Asghar Ghasemi; Alireza Asgari; Amir Nezami-Asl
Journal:  Sleep Breath       Date:  2017-09-23       Impact factor: 2.816

2.  Ischemic postconditioning confers cardioprotection and prevents reduction of Trx-1 in young mice, but not in middle-aged and old mice.

Authors:  Virginia Perez; Verónica D Annunzio; Tamara Mazo; Timoteo Marchini; Lourdes Caceres; Pablo Evelson; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2016-03-01       Impact factor: 3.396

3.  ω-3 Polyunsaturated Fatty Acid Postconditioning Protects the Isolated Perfused Rat Heart from Ischemia-Reperfusion Injury.

Authors:  Fu-Wei Zhang; Jian Tong; Yu-Sheng Yan; Qun-Qing Chen; Xiao-Ping Zhao
Journal:  Cardiorenal Med       Date:  2018-04-11       Impact factor: 2.041

4.  Effects of Nitrate Intake on Myocardial Ischemia-Reperfusion Injury in Diabetic Rats.

Authors:  Sajad Jeddi; Saeedeh Khalifi; Mahboubeh Ghanbari; Fatemeh Bageripour; Asghar Ghasemi
Journal:  Arq Bras Cardiol       Date:  2016-10       Impact factor: 2.000

5.  The Effect of Sleep Deprivation on Cardiac Function and Tolerance to Ischemia-Reperfusion Injury in Male Rats.

Authors:  Sajad Jeddi; Amir Nezami Asl; Alireza Asgari; Asghar Ghasemi
Journal:  Arq Bras Cardiol       Date:  2015-11-10       Impact factor: 2.000

6.  Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling.

Authors:  Liming Yu; Zhi Li; Xue Dong; Xiaodong Xue; Yu Liu; Shu Xu; Jian Zhang; Jinsong Han; Yang Yang; Huishan Wang
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

7.  Dose-Dependent Effects of Long-Term Administration of Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury in Male Wistar Rats: Modulation of RKIP, NF-κB, and Oxidative Stress.

Authors:  Sajad Jeddi; Sevda Gheibi; Khosrow Kashfi; Mattias Carlström; Asghar Ghasemi
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.